RNA synthesis platform to target synthesis lengths greater than 100-nt, large-scale GMP manufacturing, and novel therapeutic modifications in collaboration with industry partners Advanced-stage technology with over six years of development at the Wyss Institute at Harvard University, co-founded by Dr. George Church of Harvard Medical School, and the first spin-out from the Northpond Labs Alliance […]

Funding will support expanded offerings for drug development, regenerative medicine as fiber-optic instrument-maker broadens presence in life science market New investment will also bolster leadership team and support U.S. expansion AMSTERDAM – Optics11 Life, the fiber optics life science instrumentation company, announced today €5 million in new venture capital from FORWARD.one and returning investor Value […]

SAN DIEGO — iXCells Biotechnologies (“iXCells” or the “Company”), a high growth provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide, with special focus on primary and induced pluripotent stem cell (“iPSC”) derived cellular models, today announced receiving a growth investment from Connecticut-based Great Point Partners (“GPP”), a private […]

NEW YORK — Kaleidoscope, pioneering an operating system to accelerate research team performance, today announced the completion of a $6M seed financing round, co-led by Hummingbird Ventures and Dimension, with participation from Caffeinated Capital, SV Angel, Hawktail, and individual investors. The funding will be used to invest in product development and team expansion, with a […]

Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, visualizing results and collaborating with their peers – bridging the gap between data and discovery. DALLAS, TX – Colossal Biosciences, the de-extinction company behind the woolly mammoth and […]

After the successful closing of a USD 22.2 million Series C equity financing, Nanolive – a leading live cell imaging and analysis company – announces the appointment of two extraordinary women to its board of directors: Dr. Deborah Birx and Mrs. Victoria Wang. Nanolive participated in Venture Kick, Venture Leaders Technology and was ranked from […]

Cresset, a drug discovery software scaleup, has raised growth capital from SEP to accelerate its product development and international expansion. Cresset, a UK-based developer of drug discovery and design software, announced it has secured investment from Scottish Equity Partners (SEP), a technology focused growth equity firm. The funding will be used to support Cresset’s vision […]

Tolochenaz, Vaud, Switzerland — Nanolive SA, a leading live cell imaging and analysis company, announces today two important new additions to its board of directors. After the successful closing of a US $22.2 million Series C equity financing, Nanolive announces the appointment of two extraordinary women to its board of directors: Dr. Deborah Birx and Mrs. […]

Instrument Will Enable Near Real-Time Detection of Biomarkers and Drug Targets Fayetteville, AR – VIC Foundry, in collaboration with the University of Buffalo, has been awarded a $259,000 grant from the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program. STTR grants support research and development to de-risk new technologies that […]

La Vista, Nebraska – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment will be used to accelerate the development and commercialization of both diagnostic and research use products utilizing Ceres’ Nanotrap® technology platform. “Streck has a deep presence in and knowledge of the diagnostics industry and shares our commitment to building […]